A non-pharmacological approach to reducing device-triggered thrombosis and restenosis

Synthetic materials are commonly rejected from the body’s natural defence mechanism. However, there is untapped potential to develop synthetic materials with the innate ability to avoid the body’s natural defence mechanisms from activating. While current materials used in devices has an acceptable level of biocompatibility, there are still resounding concerns leading to device failure. This is frequently occurring in the treatment of vessels for patients with peripheral arterial disease (PAD), where restenosis remains a significant challenge for vascular surgeons.

Eli Moore, Biomaterial Specialist at TekCyte, has recently co-authored Hyperbrancked polyglycerol coated vascular stents – a non-pharmacological approach to reducing device-triggered thrombosis and restenosis.

Post Image

Explore the insights at ResearchSquare.com